|
Product complaint # (b)(4).Date sent to the fda: 3/3/2026.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.H3 investigational summary: the product was returned to eth for evaluation.Visual inspection revealed that one winding former with a detached needle and one partially dispensed suture was received for analysis.Product code vcp463g.During visual inspection of the needle.Marks were noted at the edge of the swage area.The barrel hole was examined, and a suture remnant was observed.Besides that, the suture was noted to be cut probably caused by a surgical instrument.As part of ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.
|
|
It was reported that a patient underwent a plastic and reconstructive procedure on (b)(6)
2026 and suture was used.During plastic and reconstructive surgery, during dermis suturing, the suture detached from the needle swage part.The product was used on the dermis.It was not a control release needle.Another product was used to complete the case.There were no adverse consequences to the patient.Additional information was requested.
|